Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000247177 | SCV000318635 | likely benign | Cardiovascular phenotype | 2013-04-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000726100 | SCV000515155 | likely benign | not provided | 2020-12-15 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726100 | SCV000701228 | uncertain significance | not provided | 2016-11-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001087147 | SCV000765512 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171289 | SCV001334012 | likely benign | Cardiomyopathy | 2022-04-05 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000726100 | SCV002037393 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000726100 | SCV002038316 | likely benign | not provided | no assertion criteria provided | clinical testing |